The Microphthalmia basic-Helix ± Loop ± Helix-Leucine Zipper (bHLH-LZ) transcription factor (Mi) plays a crucial role in the genesis of melanocytes; mice de®cient for a functional (Microphthalmia) gene product lack all pigment cells. We show here that the Mi activation domain resides N-terminal to the DNA-binding domain and that as little as 18 amino acids are sucient to mediate transcription activation. The minimal activation region of Mi is highly conserved in the related transcription factor TFE3 and is predicted to adopt an amphipathic alphahelical conformation. This region of Mi is also highly conserved with a region of E1A known to be essential for binding the CBP/p300 transcription cofactor. Consistent with these observations, the Mi activation domain can interact in vitro with CBP speci®cally through a region of CBP required for complex formation with E1A, P/CAF and c-Fos, and anti p300 antibodies can co-immunoprecipitate Mi from both melanocyte and melanoma cell lines. In addition, co-transfection of a vector expressing CBP2 (aas 1621 ± 1891) fused to the VP16 activation domain potentiated the ability of Mi to activate transcription, con®rming the signi®cance of the CBP-Mi interaction observed in vitro. These data suggest that transcription activation by Mi is achieved at least in part by recruitment of CBP. The parallels between transcription regulation by Microphthalmia in melanocytes and MyoD in muscle cells are discussed.
Introduction
The programme of gene expression necessary for the development of an organism is largely controlled by the regulation of transcription factors by signal transduction pathways acting to coordinate the transcriptional response to environmental cues. For some cell types it has become clear that the commitment to a speci®c lineage may be determined by the action of relatively few transcription factors expressed in a cell-type speci®c or restricted fashion. Understanding the molecular mechanisms underlying the ability of these`master-regulators' to control transcription is therefore a key issue.
The control of melanocyte development provides a particularly interesting system for understanding how the commitment and subsequent dierentiation of a speci®c cell lineage is determined by a speci®c programme of transcriptional regulation. Melanocytes, together with the retinal pigment epithelium (RPE), are responsible for skin, hair and eye colour (Silvers, 1979) and play a crucial role in the generation of action potentials in the inner ear (Steel and Barkway, 1989) . In the skin, melanocytes respond to exposure to u.v. light by increasing melanin production, the melanin then being transferred to surrounding keratinocytes as protection from u.v. damage (Fitzpatrick et al., 1979) . However, u.v.-induced sunburn can result in the transformation of the melanocyte to a cutaneous malignant melanoma, a highly aggressive and increasingly common form of cancer.
As mouse coat colour is one of the most obvious phenotypes, and because pigment cells are not essential for viability, numerous mutations aecting the melanocyte lineage have been identi®ed. Particularly important are those aecting the Microphthalmia bHLH-LZ transcription factor (Mi) (Hodgkinson et al., 1993; Hemesath et al., 1994; SteingrõÂ msson et al., 1994; Moore, 1995) . Mice lacking a functional microphthalmia gene product are completely devoid of all pigment cells, the microphthalmic phenotype resulting because the correct formation of the eye is dependent on the presence of the RPE (Raymond and Jackson, 1995) , while in humans, mutation of the mi gene is associated with Waardenberg syndrome type II (Tassabehji et al., 1994) . Transfection studies have shown that Mi is a transcription activator which can activate the expression of the tyrosinase and TRP-1 promoters (Bentley et al., 1994; Ganss et al., 1994; Hemesath et al., 1994; Yasumoto et al., 1994; Yavuzer et al., 1995) through an evolutionarily conserved sequence element termed the M-box (Lowings et al., 1992; Bentley et al., 1994) . The key role played by Mi in establishing the melanocyte lineage is underlined by the recent observation that under some circumstances Mi, but not the highly related factor TFE3 (Beckmann et al., 1990) , may convert ®broblasts to cells with melanocyte characteristics including the expression of melanogenic markers (Tachibana et al., 1996) .
Given the critical role played by Mi in melanocyte dierentiation, understanding how this factor mediates transcription activation is essential if its role in establishing the melanocyte lineage and melanocytespeci®c transcription is to be understood. Particularly intriguing in this respect is the observation that expression of the adenovirus E1A protein in melanocytes results in their de-dierentiation, and the downregulation of the Mi-responsive tyrosinase and TRP-1 genes (Yavuzer et al., 1995) . Repression is mediated through the conserved Mi-responsive element, the Mbox, and correlates with the ability of E1A to bind the CBP/p300 transcriptional cofactor (Yavuzer et al., 1995) .
CBP was ®rst isolated as a factor which mediates transcription activation by the cyclic-AMP response element binding protein CREB, in response to phosphorylation of CREB on Ser-133 (Chrivia et al., 1993; Arias et al., 1994; Kwok et al., 1994) . The highly related protein p300 (Arany et al., 1994) , initially identi®ed as a protein able to bind E1A , can also function as a co-activator for CREB (Arany et al., 1994; Lundblad et al., 1995) . More recently it has become apparent that CBP/p300 may play a crucial role in mediating the ability of several of transcription regulators to activate transcription (Bannister and Kouzarides, 1995; Battacharya et al., 1996; Chakravarti et al., 1996; Dai et al., 1996; Eckner et al., 1996; Janknecht and Nordheim, 1996; Kamei et al., 1996; Oelgeschlager et al., 1996; Oliner et al., 1996; Trouche and Kouzarides, 1996; Yuan et al., 1996; Perkins et al., 1997; Puri et al, 1997; Sartorelli et al., 1997) and that this function may be related to the ability of CBP/p300 to modulate chromatin structure either through their intrinsic histone acetyltransferase activity (Bannister and Kouzarides, 1996; or via their ability to bind the histone acetyltransferase P/CAF (Yang et al., 1996) .
On the basis of these observations we have examined the requirements for transcription activation by Mi. The results are consistent with transcription activation by Mi being mediated at least in part by recruitment of the CBP transcription cofactor to a region of Mi bearing signi®cant homology to the CBP/p300-binding region of the adenovirus E1A protein. Transcription activation by Mi in melanocytes appears to be remarkably reminiscent of transcription activation by MyoD in muscle cells.
Results

Mi contains a potent N-terminal activation domain
Transfection studies in melanoma cell lines have shown that Mi is a transcription activator and preliminary experiments using Mi deletion mutants demonstrated that the N-terminal region of the protein was essential for transcription activation (data not shown). To de®ne more precisely the requirements for transcription, various regions of Mi were expressed as Gal4 fusion proteins and their ability to activate transcription from a co-transfected Gal4-responsive reporter was assessed. As Mi can form heterodimers with other bHLH-LZ transcription factors such as TFE3 (Hemesath et al., 1994) , this approach was used to eliminate the possibility that any activation observed resulted from dimerisation between Mi and any other bHLH-LZ factor. As transfection into cells of the melanocyte lineage is relatively inecient, the Gal4-Mi expression vectors were initially transfected into 3T3 cells thereby allowing a more sensitive analysis of the requirements for transcription activation. We and others have already demonstrated that while Mi is normally expressed in a highly tissue-restricted fashion, it can nevertheless activate transcription when expressed ectopically (Bentley et al., 1994; Hemesath et al., 1994; Yasumoto et al., 1994) , implying that there may be no intrinsic cell-type speci®city in the function of the Mi activation domain. Nevertheless, to rule out the possibility that the Mi transcription factor could possess elements which might activate transcription in a tissue-speci®c fashion, we also performed the transfection assays in a melanocyte cell line, melan-c, and compared the results obtained in these cells to those generated using 3T3 cells.
A map of Mi is depicted in Figure 1a and the results from the initial transfection assays in 3T3 cells in Figure 1b . Consistent with our preliminary analysis of Mi deletion mutants (not shown), fusion of the Nterminus of Mi to the Gal4 DNA-binding domain (Gal4-Mi 1 ± 198) activated transcription up to 200-fold more eciently than expression of the Gal4 DNAbinding domain alone, con®rming that the N-terminal region of Mi contains a potent transcription activation domain. The quanti®cation of the results presented in this ®gure and in Figures 2 and 3 are shown in Figure  3g .
In melanocytes, Mi is expressed in two alternatively spliced forms which dier only by the presence of six additional amino acids (TACIFP) in the Mi(+) form of the protein (Hodgkinson et al., 1993) . To determine whether these 6 amino acids in any way in¯uenced the ability to activate transcription, we also tested a similar Gal4 fusion containing the N-terminal 198 amino acids of Mi including these additional six residues. Intriguingly the presence of the additional 6 amino acids resulted in a Gal4 fusion protein (Gal4-Mi 1 ± 198(+)) that was reproducibly able to activate transcription around two-to threefold more eciently in 3T3 cells.
Previous work on the Mi-related transcription factor TFE3, indicated that the C-terminal region of TFE3 contained a transcriptional activation domain and that this region showed a signi®cant homology to the region of Mi lying C-terminal to the DNA-binding domain (Artandi et al., 1995) . To determine whether this region of Mi could also activate transcription, the region of Mi between residue 290 and the C-terminus was fused to the Gal4 DNA binding domain (Gal4-Mi 290 ± 419) and assayed for its ability to activate the Gal4-responsive reporter. In contrast to the up to 200-fold activation observed using the Gal4-Mi N-terminus fusion, the C-terminal fusion activated transcription no more than ®vefold. Deletion of the C-terminal 16 amino acids (Gal4-Mi 290 ± 403) abolished this low level of activity and an additional deletion mutant lacking the C-terminal 54 amino acids (Gal4-Mi 290 ± 357) also failed to activate transcription. Taken together these data suggest that while the C-terminal region may activate transcription very ineciently, the major activation domain lies N-terminal to the Mi DNA-binding domain.
To determine whether there was any intrinsic dierence in the requirements for transcription activation by Mi in 3T3 cells and melanocytes, the same series of Gal4 fusion proteins were also assayed for their ability to activate transcription in the melanocyte cell line, melan-c. The results, shown in Figure 1c , are essentially very similar to those obtained using 3T3 cells, although the overall level of activation obtained is substantially reduced owing to the lower transfection eciency of these cells. Thus, as in 3T3 cells, the N-terminal region of Mi (1 ± 198) can activate transcription well, while no activation is observed with any of the C-terminal derivatives. Interestingly, in melanocytes, Gal4-Mi 1 ± 198(+) reproducibly activated transcription around 5 ± 10-fold better than the equivalent construct lacking the additional 6 amino acids, compared to the 2 ± 3-fold increase in activation observed using 3T3 cells. The possible signi®cance of this observation will be discussed later.
Homology between the minimal Mi activation domain, TFE3 and E1A
To de®ne more precisely the location of the N-terminal transcription activation domain, we assayed an additional series of Gal4 fusion proteins containing dierent regions of the Mi N-terminus. The results obtained using 3T3 cells are shown in Figure 2a . Mi residues 1 ± 150 were able to activate transcription as eciently as the entire N-terminal region (1 ± 198) when fused to the Gal4 DNA-binding domain. In contrast, residues 1 ± 129 activated transcription around tenfold less eciently, but nevertheless retained the ability to stimulate transcription around 5 ± 10-fold better than Gal4 alone. Ecient activation, only around twofold less than with the entire Nterminal region, was also observed in the absence of the N-terminal 105 amino acids of Mi, irrespective of whether the C-terminus extended either to residue 198 (Gal4-Mi 106 ± 198) or to 150 (Gal4-Mi 106 ± 150). The Mi activation domain therefore appears to lie within the 44 amino acids de®ned by the 106 ± 150 deletion mutant.
In melanocytes the results ( Figure 2b ) were very similar to those obtained using 3T3 cells, though again the fold activation observed was much reduced. Thus, Gal4-Mi 1 ± 129 activated transcription much less eciently than Gal4-Mi 1 ± 198, while both the 106 ± 198 and the 106 ± 150 derivatives also activated transcription at levels signi®cantly above that obtained using the Gal4 DNA-binding domain alone, though in these cells the relative-fold activation was somewhat variable compared to the Gal4-Mi 1 ± 198 protein.
Close inspection of the region of Mi between residues 106 and 150, de®ned by the deletion series as being sucient to act as an activation domain is instructive. Amino acids 103 to 141 of Mi were compared with the N-terminal 39 amino acids of the related bHLH-LZ transcription factor TFE3 and with the N-terminus of the adenovirus E1A gene product. E1A was included in the alignment since we have shown previously that E1A can repress transcription directed by the Mi target sequence, the M-box, by binding the p300/CBP transcription co-factor (Yavuzer et al., 1995) . Since E1A-mediated transcription repression is believed to result from E1A acting to partition these co-factors from cellular transcription factors, it was possible that E1A and Mi could bind the same proteins and that this would be re¯ected in sequence similarity between Mi and E1A. The result of this alignment is shown in Figure 3a where residues which are identical or which have very similar properties are boxed.
It is evident that the most homology between Mi and TFE3 lies between residues 115 and 133. In this alignment, the proline and glycine residues, which would tend to be incompatible with the formation of an alpha-helix are highlighted. It is striking that the region of Mi which is most homologous to TFE3 contains no glycine or proline residues, raising the possibility that this region of Mi may adopt an alphahelical conformation. Also shown is the alignment with the N-terminus of E1A. A signi®cant match between E1A on the one hand, and Mi and TFE3 on the other is observed within the N-terminal half of the Mi-TFE3 homology region. Using a helical wheel analysis it can be seen ( Figure 3b ) that all three proteins have the potential to adopt an amphipathic alpha-helical conformation with one face comprising entirely hydrophobic residues, and the other comprising either acidic or hydrophilic residues. Signi®cantly, fusion of residues 114 ± 132, which spans the potential alpha-helical region, to the Gal4 DNA-binding domain activated transcription almost as eciently as residues 106 ± 150 in 3T3 cells (Figure 3c ). This region is also sucient to confer the ability to activate transcription eciently in melanocytes ( Figure  3d ). To con®rm the importance of this region for transcription activation, two additional Gal4 fusions were made in which speci®c in-frame deletions (DIISLE and DEEILGLMD) were introduced in the context of the Gal4-Mi 1 ± 198 fusion protein. The locations of these deletion mutants are indicated in Figure 3a . While the DEEILGLMD mutation, which lies outside the highly conserved region had little eect on activation in 3T3 cells (Figure 3e ), the DIISLE mutation, located within the region conserved between Mi and TFE3 and overlapping the E1A homology, reduced activation by around tenfold but nevertheless retained the ability to activate transcription significantly above that of Gal4 alone (Figure 3f ). Taken together these data highlight the importance of the conserved region between residues 115 and 132 in activation of transcription by Mi.
Interaction between Mi and the transcriptional cofactor CBP
The region of Mi between residues 114 and 132 is sucient to activate transcription when fused to the Gal4 DNA-binding domain. This region of Mi also exhibits signi®cant sequence and potential structural homology to the N-terminus of adenovirus E1A in a region of E1A essential for the interaction with the CBP/p300 transcription co-factor (Wang et al., 1993) . The homology, together with the fact that the interaction between E1A and p300/CBP is required for E1A-mediated repression of the Mi target site, the M-box (Yavuzer et al., 1995) , raised the possibility that Mi might also interact with p300/CBP.
Although CBP has been shown to interact with several cellular transcription factors, many of these interactions are restricted to two regions of CBP which have been termed (Bannister and Kouzarides, 1995) CBP1 (residues 461 ± 661) and CBP2 (residues 1621 ± 1891) (Figure 4a ). Thus, CBP1 can interact with Myb, c-Jun and phosphorylated CREB, while CBP2 has been shown to interact with the histone acetyltransferase P/ CAF, c-fos and with E1A. If the homology between the N-terminal domain of E1A and the activation domain of Mi were signi®cant we would expect Mi, like E1A, to interact speci®cally with the CBP2 subdomain of CBP. To investigate this possibility, CBP1 or CBP2 were expressed as GST fusion proteins in E. coli, puri®ed and used in GST-`pull-down' assays with in vitro transcribed/translated Mi or the Mi derivatives depicted in Figure 4b . The results using WT Mi are shown in Figure 4c . In this assay, neither GST alone, nor GST fused to the CBP1 domain were able to bind Mi. In contrast, Mi bound strongly both to the CBP2 domain and to a smaller region of CBP2 lying between residues 1697 and 1858 (CBP3). Thus, Mi, like E1A, binds speci®cally to CBP2, a result consistent with the homology observed between the two proteins.
We next asked which region of Mi was required for the interaction with CBP2. Consistent with the Mi activation domain residing within the N-terminus of Mi, Mi residues 1 ± 198 (Mi DC198) were able to interact with GST-CBP2 (Figure 4d ). Only a very low level of non-speci®c binding was observed using either GST alone or GST-CBP1. No binding was observed if the ®ve residue in-frame deletion (DIISLE) which severely reduces the function of the Mi activation domain (see Figure 3f ) was also introduced into this protein (Mi DC198 DIISLE) (Figure 4e) . In contrast to Transcription activation by Microphthalmia S Sato et al the interaction observed using the N-terminal 198 residues of Mi, the C-terminal 122 amino acids of Mi (DN298), which, compared to the N-terminal region, does not activate transcription signi®cantly (see Figure  1 ), failed to interact with either CBP1 or CBP2 ( Figure  3f ). However, if the entire C-terminus of Mi, including the DNA-binding and dimerisation domain, but lacking the N-terminal activation domain (DN200) is used, binding to GST-CBP2 is restored (Figure 4g ). Taken together these data suggest that the Mi Nterminus and the bHLH-LZ domain may each independently interact with the CBP2 region of the CBP transcription co-factor.
Mi and CBP interaction in vivo
The evidence available from the homology with E1A and the interaction between Mi and CBP in vitro, strongly suggested that the transcription activation by Mi may at least in part be mediated by the recruitment of the CBP/p300 transcription cofactor.
To investigate the functional implications of the Mi-CBP interaction, we asked whether Mi and CBP could cooperate in activation of transcription in vivo.
To this end, we initially expressed either full length Mi or the DIISLE derivative as Gal4 fusions either alone or together with the CBP1 or CBP2 domains of CBP fused to the VP16 activation domain. Based on the in vitro interaction assays presented above, we anticipated that superactivation resulting from an interaction between Mi and the CBP-VP16 fusion proteins would only be observed when WT Mi and CBP2-VP16 were co-expressed. The results are shown in Figure 5a . Consistent with our previous results, little activation is observed using the DIISLE derivative compared to Gal4 Mi WT protein and co-expression of CBP1-VP16 fails to aect activation of the reporter in the presence of either Gal4-Mi or Gal4 Mi DIISLE. In contrast, expression of CBP2-VP16 results in superactivation of Gal4 Mi (4 to 5-fold) but not Gal4-Mi DIISLE. This result is therefore consistent with the in vitro interaction assays which suggested that CBP2, but not CBP1 could interact with Mi. As the N-terminal region of Mi was sucient to confer transcription activation, we also asked whether this region could also interact speci®cally with CBP2 in vivo. The N-terminal domain of Mi fused to Gal4 (Gal4-Mi 1 ± 198(+))was therefore expressed either alone or together with derivatives of CBP in which the sub-domains CBP1 or CBP2 were fused to the VP16 transcription activation domain. Consistent with CBP interacting with the N-terminal region of Mi, co-expression of the Gal4-Mi 1 ± 198(+) protein with CBP2-VP16 augmented the activation by the Gal4-Mi fusion protein up to sevenfold, while no enhancement of activation by Mi was observed using the CBP1-VP16 expression vector. The results from these in vivo cooperation assays therefore con®rm the results obtained from the in vitro binding experiments, and suggest that Mi activation may be mediated at least in part by speci®c interaction with CBP via the CBP2 subdomain.
Finally, we also attempted to detect interaction between Mi and CBP/p300 using a co-immunoprecipitation assay. Cell extracts from either the melanocyte cell line melan-c or the melanoma cell line B16 were immunoprecipitated using an anti-p300 monoclonal antibody and the immunoprecipitated protein analysed by SDS ± PAGE and Western blotting using a speci®c anti-Mi polyclonal antibody. The results obtained (Figure 5c ) indicate that following immunoprecipitation using the anti-p300 antibody, anity puri®ed antiMi antibody speci®cally detected two bands, most likely representing dierentially phosphorylated forms of Mi. The same pattern of bands was apparent if melan-c cells were ®rst labelled with 35 S-methionine before direct immunoprecipitation with anti-Mi antibody. ) GST`pull-down' assays showing interaction between Mi and the CBP2 sub-domain. CBP2 or CBP1 were expressed as GST fusion proteins in E. coli, puri®ed using glutathione sepharose and the sepharose bound protein used to bind 35 S-labelled Mi or the indicated Mi derivatives. GST was used as a negative control. After extensive washing protein retained on the sepharose beads was analysed by SDS ± PAGE Transcription activation by Microphthalmia S Sato et al
Discussion
The Microphthalmia transcription factor plays a crucial role in melanocyte development; mice lacking a functional microphthalmia gene product are devoid of all pigment cells. As a ®rst step towards understanding the role of Mi in melanocyte development, we have examined the requirements within Mi for transcription activation. The results reveal that the N-terminus of Mi contains a potent transcription activation domain, with residues 114 ± 132 being sucient to confer transcription activation in both 3T3 cells and in melanocytes. This result also indicates that there is no intrinsic cell-type speci®city in the ability of the Mi activation domain to induce transcription, and is consistent with the strong homology between the Mi-activation domain and the activation domain located in the N-terminus of thè ubiquitous' and highly related transcription factor TFE3 (see Figure 3a and Artandi et al., 1995) . Structural considerations based on an absence of helix-breaking' residues within the activation domains of the two proteins, and a`helical wheel' analysis suggest that both activation domains may form an acidic amphipathic alpha-helix. Although we have not investigated this possibility further, similar predictions have been made for many transcription activation domains (see Triezenberg, 1995, and references therein) . However, the picture emerging from several studies is that activation domains in isolation may be unstructured, but may adopt a speci®c conformation on interaction with their target molecules. Such aǹ induced-®t' model appears to be borne out by the recent determination of the crystal structure of the p53 activation domain complexed with the MDM2 repressor (Kussie et al., 1996) . In the complex, the p53 activation domain is revealed to comprise an alpha-helix in which speci®c hydrophobic residues are buried in the interface with MDM2. The prediction that the Mi activation domain may adopt an alphahelical conformation is consistent with this model.
In addition to the similarity with the related bHLH-LZ transcription factor TFE3, the Mi activation domain also exhibited a signi®cant homology with a region of the adenovirus E1A protein known to be essential for the interaction between E1A and the CBP/ p300 transcription cofactor. The signi®cance of this homology was underlined both by the fact that the Nterminal region of Mi, but not the activation-impaired DIISLE mutant, could interact with CBP in vitro, and more speci®cally, by the observation that interaction was observed between Mi and the CBP2 subdomain of CBP, which interacts with E1A (Bannister and Kouzarides, 1995) , but not with the CBP1 subdomain, which does not.
We were able to reproduce in vivo the speci®city of the CBP-Mi interactions observed in vitro, by using a mammalian 2-hybrid assay in which the CBP subdomains, CBP1 and CBP2, were expressed as fusions with the VP16 activation domain, while Mi was fused to the Gal4 DNA-binding domain; CBP2-VP16 enhanced activation by Gal4-Mi 1 ± 198 up to sevenfold and full length Mi around fourfold, while no super-activation was observed by coexpressing the CBP1-VP16 protein, or by co-expressing CBP2-VP16 with the DIISLE Mi which fails to interact with CBP in vitro. Thus, both the in vitro interaction assays together with the in vivo mammalian 2-hybrid results implicate the CBP2 sub-domain of CBP in transcription activation by Mi. If these data are viewed together with our previous observations that the Mitarget site, the M-box, is speci®cally repressed by E1A in a CBP/p300-dependent fashion, that repression by E1A could be reversed by overexpression of Mi (Yavuzer et al., 1995) , and that Mi may be coimunoprecipitated with p300, it seems likely that the interaction between CBP and Mi characterised here is functionally signi®cant. That is not to say that the only way Mi may activate transcription is via interaction between CBP/p300. Rather, we view the Figure 5 Mi and CBP interact in vivo. (a) CAT assay performed after a vector expressing the Gal4 DNA-binding domain fused to full length Mi or full length Mi containing the DIISLE mutation (150 ng) was transfected into B16 melanoma cells either alone, or together with vectors expressing either the CBP1 or CBP2 subdomains fused to the VP16 activation domain (300 ng). (b) Gal4-Mi 1 ± 198(+) (100 ng) was expressed into 3T3 cells either alone or together with CBP, or the CBP1-VP16 or CBP2-VP16 proteins (600 ng). The reporter used was the same as that used throughout this study. The activation obtained by co-expressing CBP or its derivatives is presented relative to that obtained using the Gal4-Mi WT or Gal4 Mi 1 ± 198 proteins. (c) Co-immunoprecipitation of Mi and p300. Cell lysate derived from either the melanocyte cell line melan-c or B16 melanoma cells was immunoprecipitated using a mouse anti-p300 monoclonal antibody and the immunoprecipitate subjected to SDS ± PAGE and Western blotting using a rabbit anti-Mi polyclonal antiserum. As a control, cells were labelled with Mi activation domain as a scaold on which many interactions may take place. For example, interaction with CBP/p300 may target its associated histone deacetylase activities (Bannister and Kouzarides, 1996; Ogryzko et al., 1996; Yang et al., 1996) to Mi-responsive promoters and thereby play a significant role in chromatin opening on some genes at speci®c stages of melanocyte development or differentiation, while the interaction with other co-factors may be relevant in other circumstances. In this respect it may be signi®cant that the Mi activation domain can function eciently in yeast which are not known to possess any genes directly analogous to CBP (KR and CRG unpublished observations).
Although we have established that the Mi activation domain can bind the CBP transcription cofactor through a region of the protein with signi®cant similarity to E1A, binding of CBP to E1A requires residues outwith this core element. Speci®cally, mutation of three amino acids, around 60 amino acids C-terminal to the conserved region abolishes interaction between E1A and CBP (Wang et al., 1993) . Given so little information on the precise determinants of CBP-E1A interaction it is dicult to assess whether such a similar requirement exists in Mi. Nevertheless, examination of the 6 amino acids present uniquely in the alternatively spliced form of Mi reveal a triplet of residues, IFP, identical to those found in a region of E1A (Ad5) identi®ed by mutagenesis to be essential for binding CBP. Although we have tried unsuccessfully to demonstrate that these residues contribute signi®cantly to the anity of Mi for CBP in vitro (not shown), it is intriguing that transcription activation by Gal4-Mi 1 ± 198(+), compared to the same protein lacking the additional six residues, is around threefold higher in 3T3 cells and 7 ± 10-fold higher in melanocytes. Further experiments are clearly needed to establish whether in vivo these residues contribute to the stability of the interaction with CBP.
In addition to interacting with the Mi activation domain, we have also observed in vitro, speci®c interaction between the Mi DNA-binding domain and CBP. In this respect the interaction between Mi and CBP resembles that between CBP and MyoD where both the activation domain and the DNA-binding domain have been implicated in CBP binding. However, while Eckner et al., (1996) have demonstrated that the DNA-binding domain of MyoD is sucient to mediate transcription activation via CBP interaction, Sartorelli et al., (1997) demonstrated that the MyoD activation domain could confer p300-dependent coactivation but that the bHLH domain was not sucient. We have been unable to achieve transcription activation by coexpressing the Mi DNAbinding domain with CBP (data not shown) and as such our data on Mi are more similar to those obtained by Sartorelli et al. It is entirely possible however, that high anity binding by CBP to Mi requires interaction with both the activation and DNAbinding domains and that this will only be achieved after direct DNA-binding. A similar mechanism has been proposed for MyoD and cited to account for the failure to detect MyoD-CBP/p300 complexes after direct immunoprecipitation . Further work is required to clarify whether the potential of CBP/p300 to regulate Mi or MyoD through the DNA-binding domain is meaningful.
What is the signi®cance of the interaction between Mi and CBP? We view it as likely that the ability of Mi to activate transcription is tightly regulated. In this respect, preliminary evidence suggests that Mi is regulated by the MAPkinase cascade by phosphorylation on a speci®c serine residue in the N-terminus of the protein (our unpublished observations). However, interaction with CBP would endow Mi with a far higher degree of potential regulation. Thus p300 is known to be dierentially phosphorylated in the cell cycle (Yacuik and Moran, 1991) and is a substrate for Cdk2 and Cdc2 (Banerjee et al., 1994) and ERK2 (Janknecht and Nordheim, 1996) in vitro, although the signi®cance of these phosphorylation events is unknown. Moreover, recent evidence indicates that some transcription factors may be regulated by p300-associated cyclin-cdk complexes (Perkins et al., 1997) . The regulation of CBP and its associated activities is likely to provide Mi and other CBP-interacting transcription factors with a great deal of¯exibility in their response to dierent growth factors and other environmental cues, and may enable productive interactions between dierent DNA-binding transcription factors which interact with dierent subdomains of CBP.
Finally, the similarity between the control of melanocyte-speci®c transcription and dierentiation by Mi, and the role of MyoD in muscle is striking. The activation domains and the DNA-binding domains of both proteins interact independently with CBP/p300, and E1A, through binding CBP/p300, can prevent myogenesis (Webster et al., 1988; Braun et al., 1992; Mymryk et al., 1992; Caruso et al., 1993) or dedierentiate melanocytes (Yavuzer et al., 1995) . Both proteins interact with p105Rb (Gu et al., 1993; Yavuzer et al., 1995) , and both MyoD and Mi can in some circumstances activate the programme of muscle or melanocyte-speci®c transcription respectively when heterologously expressed in ®broblasts (Davis et al., 1987; Tapscott et al., 1988; Tachibana et al., 1996) . These common features may re¯ect an underlying similarity in the mechanisms operating during the commitment and dierentiation of muscle and pigment cell types.
Materials and methods
Plasmids
The CMV Mi expression vector has been described previously (Yavuzer et al., 1995) as has the mammalian Gal4 expression vector, pG424 (Sadowski and Ptashne, 1989) . All Mi mutants were derived by PCR using appropriate primers and the cloned products veri®ed by sequencing.
The CAT reporter used, pG5E4CAT, containing 5 Gal4 binding sites located upstream of the minimal adenovirus E4 promoter linked to the CAT gene, has been described previously (Lillie and Green, 1989) . Results obtained using this reporter were essentially identical to those obtained using a reporter containing a single Gal4 binding site with the exception that the level of CAT activity obtained was around tenfold higher. The GST-CBP1, GST-CBP2, CBP1-VP16 and CBP2-VP16 constructs have all been described previously (Bannister and Kouzarides, 1995) .
Cells and transfection assays
3T3 cells and B16 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% foetal calf serum. (FCS). Melan-c cells (Bennett et al., 1989) were grown in RPMI1640 supplemented with 10% FCS and 200 ng/ml phorbol 12-myristate 13-acetate and 100 mM bmercaptoethanol.
Transfections were performed using lipofectamine reagent (BRL). Cells at around 40% con¯uency in 5 cm dishes were washed twice in serum-free medium and 1.7 ml serum free medium added. A total of 1 mg DNA in 100 ml serum-free medium was mixed with an appropriate amount of lipofectamine in 200 ml serum-free medium, left for 20' at RT and then added to the cells. After 5 h at 378C, the medium was removed and the cells washed once in serum-free medium before the addition of 4 ml medium with serum. Cells were harvested 2 days later and processed. The optimal amount of lipofectamine used per mg DNA was determined empirically for each batch of lipofectamine and was found to vary between 1 and 14 ml. All transfections were repeated using dierent preparations of DNA, and pCH110 containing the SV40 promoter driving expression of a lacZ reporter was used as an internal control for transfection eciency (between 200 and 400 ng per transfection). CAT and bgalactosidase assays were performed as described (Yavuzer and Goding, 1994) . CAT assays were quantitated using either a Phosphorimager or by excising the spots and scintillation counting.
GST pull-down assays
For the GST pull-down assays, Mi or its derivatives were cloned into the BamHI site of the in vitro transcription/ translation vector pLINK under the control of the T7 promoter. In vitro transcription/translation (ITT) of the Mi derivatives was performed using the TNT kit (Promega). GST-CBP fusions were expressed in E.coli and puri®ed using glutathione-sepharose beads. For the interaction assays, GST or GST-CBP fusion protein bound to sepharose beads was mixed with 35 S-labelled ITT Mi, and after 1 h incubation were washed extensively, essentially as described (Bannister and Kouzarides, 1995) . Proteins retained on the beads were subsequently analysed by SDS ± PAGE and autoradiography.
Antibodies and immunoprecipitations
For the production of anti-Mi antibody, residues 13 ± 75 of Mi, which are not homologous to the highly-related bHLH-LZ factors TFE3, TFEC and TFE3, were expressed as a fusion protein with GST in E.coli strain BL21. The GST-Mi fusion protein was puri®ed using glutathione-sepharose beads and, after elution from the beads, was used for injection into rabbits. Anti-GST antibodies were removed from the antiserum raised by incubation with an excess of GST protein bound to glutathione-sepharose beads. Anti-Mi antibodies were subsequently anity puri®ed by passage over a column containing the GST-Mi fusion protein and after extensive washing, the bound anti-Mi antibody was eluted in 1 ml fractions using a low pH buer (100 mM Glycine pH 2.5, 0.1% Triton X-100) and immediately neutralised with 100 ml Tris.HCl pH 8.0. Eluted antibody was then dialyzed at 48C against PBS. The resulting anity puri®ed antibody was highly speci®c, and could be used both to immunoprecipitate Mi and to detect Mi in Western blots.
The anti-p300 antibody used for the co-immunoprecipitation experiments was obtained from Pharmingen. For the p300-Mi co-immunoprecipitations, cell lysates and immunoprecipitations were performed essentially as described (Avantaggiati et al., 1996) with the exception that the lysis buer contained 150 mM NaCl. For the Mi immunoprecipitations, melan-c cells were labelled with 35 S-methionine for 5 h (0.5 mCi/9 cm tissue-culture dish), lysed in RIPA buer (50 mM Tris.HCl pH 8.0, 0.1% SDS, 500 mM NaCl, 1% Triton X-100) and incubated with anti-Mi polyclonal antiserum overnight at 48C. Protein A sepharose beads were then added, rotated for 1 h, pelleted by centrifugation and the bound protein analysed by SDS ± PAGE after extensive washing in RIPA buer without SDS.
